Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
GemVax & KAEL reports further positive data from GV1001 Phase II Alzheimer's Disease trial 2020-11-23 20:00
Fresenius Kabi and ASPEN partner for an expert interview series on omega-3 fatty acid containing parenteral nutrition 2020-11-23 19:00
Innovent Announces NMPA Granted New Indication Approval for SULINNO® (Adalimumab Injection) in China for the Treatment of Polyarticular Juvenile Idiopathic Arthritis 2020-11-23 18:34
Ascentage Pharma Receives Approvals for Two Phase Ib/II Clinical Studies of the Bcl-2 Inhibitor APG-2575 for the Treatment of Waldenström Macroglobulinemia and Multiple Myeloma in China 2020-11-23 18:32
Huami Corporation Reports Third Quarter 2020 Unaudited Financial Results 2020-11-23 17:10
Zymo Research Receives CE IVD Mark for its Quick-DNA/RNA™ Viral MagBead Kit 2020-11-23 14:05
Picosun's medical ALD solutions enable safer surgeries 2020-11-23 10:54
Rewardz Empowers Employees with Joye - A Mental Wellness & Self-Care Offering 2020-11-23 10:00
ESMO ASIA Congress 2020 | CStone Pharmaceuticals announces the results of GEMSTONE-302, Sugemalimab has the potential to provide a new treatment option for patients with advanced NSCLC 2020-11-23 09:30
CGTN: China calls for more inclusive development in post-COVID world 2020-11-23 09:09
Infinitus Harnesses eCommerce to Offer Greater Direct Selling Opportunities for Partners 2020-11-23 09:00
Creation of a research partnership between Pierre Fabre and Y-Biologics for the development of new immunotherapies based on monoclonal antibodies 2020-11-23 09:00
G20 Riyadh Summit: Release of Leaders' Declaration 2020-11-23 08:30
Innovent Releases Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Biosimilar Injection) as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (HCC) at ESMO ASIA Virtual Congress 2020 2020-11-23 08:00
Firestorm Fire Protection PTY Announces Rebranding, Changes Name to United Safety 2020-11-23 07:00
Novel Antioxidant Seen as an Effective Strategy for Peripheral Artery Disease 2020-11-20 23:07
Antengene Corporation, an Innovative Cancer Biotech Company, is Listed on the Main Board of the Hong Kong Stock Exchange 2020-11-20 21:09
INOVIO Presents Clinical Results of its DNA Medicines INO-5401 + INO-9012 in Novel Combination with PD-1 Inhibitor Libtayo® (cemiplimab) in the Treatment of Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 2020 Annual Meeting 2020-11-20 21:00
RedHill Biopharma Initiates Phase 3 Study of RHB-204 for First-Line Treatment of NTM Disease 2020-11-20 21:00
Ortho's CE-Marked VITROS® SARS-CoV-2 Antigen Test Detects Asymptomatic COVID-19 Individuals 2020-11-20 20:00
1 611 612 613 614 615 1533